AbCellera Biologics Inc ABCL Balance Sheet

Income Statement

Quarter End	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	1.54B	1.5B	1.54B	1.51B	1.49B	1.46B	1.41B	1.49B
Total Current Assets	1.03B	940.65M	930.74M	919.52M	871.99M	813.95M	771.55M	871.99M
Cash and Equivalents	386.54M	193.02M	179.75M	172.42M	133.32M	123.57M	148.31M	133.32M
Total Non-Current Assets	732.67M	790.45M	866.07M	869.88M	903.81M	955.23M	959.81M	903.81M
Total Liabilities	307.63M	289.42M	342.34M	329.42M	335.78M	333.18M	301.51M	335.78M
Total Current Liabilities	118.32M	89.59M	118.91M	110.24M	119.01M	104.88M	70.38M	119.01M
Total Non-Current Liabilities	189.31M	199.83M	223.43M	219.18M	216.76M	228.3M	231.13M	216.76M
Common Equity	734.37M	742.82M	744.76M	747.91M	753.2M	764.56M	769.97M	753.2M
Retained Earnings	426.19M	386.08M	355.55M	326.94M	279.79M	239.18M	202.25M	279.79M

Year End December 30 2023	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	1.01B	1.32B	1.54B	1.49B
Total Current Assets	813.33M	929.8M	1.03B	871.99M
Cash and Equivalents	594.12M	476.14M	386.54M	133.32M
Total Non-Current Assets	830.51M	1.03B	1.23B	1.15B
Total Liabilities	175.03M	292.84M	307.63M	335.78M
Total Current Liabilities	103.49M	120.68M	118.32M	119.01M
Total Non-Current Liabilities	73.74M	172.16M	189.31M	216.76M
Total Equity	830.51M	1.03B	1.23B	1.15B
Common Equity	716.31M	757.79M	734.37M	753.2M
Retained Earnings	114.2M	267.67M	426.19M	279.79M